Democratic Republic of Congo Guinea
Project ongoing
Evaluation of the efficacy of a post-exposure prophylaxis (PEP) strategy in contacts at high risk of developing Ebola virus disease (EVD)
Evaluation of the efficacy of a post-exposure prophylaxis (PEP) strategy in contacts at high risk of developing Ebola virus disease
Multinational, multicentre, multi-epidemic, phase III, comparative, controlled, randomised, superiority trial with open parallel arms.
Main objective
To compare the efficacy of Inmazeb and obeldesivir combined with Ervebo® vaccine vs. Ervebo® alone in preventing infection in high-risk contacts of patients with MVE.
Secondary objectives
– Assessing the safety and tolerability of Inmazeb and obeldesivir combined with Ervebo vaccine
– Evaluate the clinical, biological and virological severity of the disease among included patients who have developed confirmed EVM
Alice Montoyo
alice.montoyo@coral.alima.ngo
Discover our activities
in research and teaching
of Bordeaux's university sites.
. University of Bordeaux
. Institute of Public Health, Epidemiology and Development (Isped)
. Bordeaux Population Health Research Center (BPH)
. Bordeaux School of Economics (BSE)
. Sciences Po Bordeaux
Click on the names of the countries where we operate below the map!
